Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol

Detalles Bibliográficos
Autores principales: Zeng, Yan-Ming, Xu, Xiao-Lei, He, Xiao-Qing, Tang, Sheng-Quan, Li, Yao, Huang, Yin-Qiu, Harypursat, Vijay, Chen, Yao-Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213617/
https://www.ncbi.nlm.nih.gov/pubmed/32149772
http://dx.doi.org/10.1097/CM9.0000000000000790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213617/
https://www.ncbi.nlm.nih.gov/pubmed/32149772
http://dx.doi.org/10.1097/CM9.0000000000000790

Ejemplares similares